Christophe Weber
President, CEO and Representative Director, Takeda Pharmaceuticals
Christophe Weber is President, Chief Executive Officer, and Representative Director of Takeda Pharmaceutical Company, where he has led the company’s global transformation, including the globalization of its operations, a major shift in R&D strategy, and strengthened governance and ethical standards. Since becoming CEO in 2015, he has overseen Takeda’s evolution into a leading global biopharmaceutical company operating across highly diverse regulatory, pricing, and financing environments. Prior to Takeda, Christophe spent more than 20 years at GlaxoSmithKline, holding senior leadership roles across Europe, Asia, and the United States. He brings deep experience on how geopolitics, market dynamics, and policy choices shape pharmaceutical innovation, access, and sustainable health financing.